Skip to main content
Heranba Industries Limited logo

Heranba Industries Limited — Investor Relations & Filings

Ticker · HERANBA ISIN · INE694N01015 LEI · 335800OPXIEPYCNRWS37 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2026-02-27 Regulatory Filings
Country IN India
Listing BSE.NS HERANBA

About Heranba Industries Limited

https://www.heranba.co.in/

Heranba Industries Limited specializes in the manufacturing and marketing of synthetic pyrethroids and their intermediates. The company operates an integrated business model spanning the production of technicals, formulations, and branded products. Its extensive portfolio includes key active ingredients such as Cypermethrin, Deltamethrin, Alpha Cypermethrin, and Permethrin, catering to agriculture, public health, and animal health sectors. With multiple manufacturing facilities and dedicated R&D capabilities, the company provides a wide range of insecticides, herbicides, and fungicides. Heranba maintains a global footprint, supplying products to over sixty countries while ensuring quality control from intermediate stages to final crop protection solutions.

Recent filings

Filing Released Lang Actions
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the filing of an application under the Insolvency and Bankruptcy Code (IBC) against the company's 100% wholly owned subsidiary. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material events. The document provides details about the insolvency petition filed with the National Company Law Tribunal (NCLT), including parties involved, claim amount, reasons, and expected impact. The document is an announcement of a material event (filing under IBC) rather than a financial report, audit, or management discussion. It is a regulatory disclosure under SEBI LODR, fitting the category of Regulatory Filings (RNS). The document length is 3665 characters, relatively short and focused on disclosure rather than detailed financial data or report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-02-27 English
Copy of Newspaper Publication
Earnings Release Classification · 90% confidence The document is a BSE/NSE stock exchange notice dated February 13, 2026, titled “Newspaper Publication of Financial Results for Quarter ended on December 31, 2025.” It informs the exchanges that the board-approved quarterly and nine-month results have been published in various newspapers and encloses the newspaper extract showing key financial metrics (revenue, net profit, EPS, etc.). This matches an initial announcement of quarterly/periodical financial results (key highlights only), which corresponds to the Earnings Release category (ER). 9M 2025
2026-02-13 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a SEBI Listing Regulation-compliant announcement of un-audited quarterly financial results approved by the Board of Directors, including full income statement tables for the quarter and nine months ended December 31, 2025, along with an auditor’s limited review report. It contains substantive financial data (actual numbers, profit/loss, revenue breakdown) rather than just highlights or a link to a report. Under the definitions, this constitutes an Interim/Quarterly Report (IR). Q3 2026
2026-02-11 English
Appointment
Board/Management Information Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the appointment of an internal auditor. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to disclosures about changes in company management or appointments. The content focuses on the appointment of ZMAS and Associates as the internal auditor for a specified period. There are no financial statements, earnings data, or detailed reports included. The document is an announcement of a management-related change rather than a full report or financial disclosure. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is 3069 characters, which is relatively short and consistent with an announcement rather than a full report.
2026-02-11 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 88% confidence The document is an announcement of the Board meeting outcome under SEBI Listing Regulations where the Board approved the unaudited financial results for the quarter ended December 31, 2025, and it includes the full financial results table (income, expenses, tax, profit, etc.) for the quarter and nine months period. This constitutes substantive financial statements for a period shorter than a full fiscal year, meeting the definition of an Interim/Quarterly Report. It is not merely an announcement of publication nor just a summary earnings release; it contains detailed interim financial data. Q3 2026
2026-02-11 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-02-04 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.